07 Dec

HealthBeacon Wins eHealth Innovation of the Year

Digital Therapeutic company, HealthBeacon Wins eHealth Innovation of the Year at the Irish Medtech Awards.

HealthBeacon was honoured last night as the eHealth Innovation of the Year at the Irish MedTech Awards. This award is to recognise the integration of ICT in the world of healthcare and rewards the best eHealth/ mHealth solutions produced by the eHealth sector. This award was presented by John Shiel , Senior Development Advisor, Life Sciences Dept, Enterprise Ireland and was received by Kieran Daly, CTO and Joyce Power, Quality Manager.

This award caps a successful 2018 for HealthBeacon that includes achieving FDA clearance, a doubling of markets served, as well as multiple industry awards in Europe and North America.

The evening’s winners were revealed at a black tie gala evening where the best of Ireland’s medtech industry were recognized and celebrated in front of hundreds of senior executives.

In addition, HealthBeacon was invited to attend the two-day Medtech Rising: CEO Conference and Awards, as well as, an opportunity to host a stand at Medtech Rising which is attended by 500 professionals.

About HealthBeacon

HealthBeacon is a Digital Therapeutics company that develops smart tools for managing medication. HealthBeacon has developed an injectable medication management system that tightly monitors patients digitally, keeping them adherent to their prescription and leveraging real time data to drive clinical intervention. This system has been clinically reviewed, validated by the pharmaceutical industry and has been integrated into patient care programs throughout North America and Europe, delivering valuable data to both the patient and their clinical team.

24 Oct

Funding and Scaling Series

HealthBeacon CEO, Jim Joyce participated in a “fire side chat” at an investment event for the “Funding and Scaling Series” in Dublin on Tuesday. The event is being hosted by Dublin Business Innovation Centre (Dublin BIC) which provides business consultancy services to early stage, high potential start-ups.

As a serial entrepreneur, Jim was asked to present to the crowd of 300-400 attendees comprised of entrepreneurs, investors and business leaders due to his success in raising funds as HealthBeacon has successfully completed two rounds of funding in the last three years and will be seeking a third round of funding in the coming months.

The event is part of the Dublin BIC Funding and Scaling series, a quarterly breakfast briefing, which was introduced by Dublin BIC in November last year. These briefings offer entrepreneurs the opportunity to explore different approaches to fundraising and scaling for start-ups. It involves hearing the perspectives of investors and learning from those that have successfully funding and scaled their business.

In addition to the presentation regarding his own success, from start-up to scale-up, Jim will join a panel of entrepreneurial peers to answer questions that prepare start-ups for potential investment.

20 Oct

HealthBeacon Builds Bridges into Latin American Market

Over the next few quarters, HealthBeacon will embark on several strategic initiatives to expand our global influence and educate new markets about our award-winning technology. As part of HealthBeacon’s global growth initiatives, we were proud to welcome several key influencers from Latin America into the HealthBeacon Dublin headquarters.  The HealthBeacon team was joined by Doctor Valéria Camargo, Medical Director of Auditing, OMINT, Mr. Márcio do Lago, Executive Director, ABCIS (Brazilian Association of CIOs) and Mr. Aimar Tarrufi, Senior Claims Director, SUL AMERICA. Also joining the team in Dublin was our LATAM manager, Andrea Rangel who is based in our São Paulo facility.

The delegates took part in a workshop to learn about the HealthBeacon technology and the potential for connected medicine in Latin America. The LATAM market has a large patient base where Brazil alone could serve millions of patients afflicted with diseases where biologic treatments are used. The workshop participants brought a global perspective for medical technology, healthcare, pharmaceutical, health insurers and information technology to discuss the future of connected medicine and digital therapies. Furthermore, these senior decision makers have a particular expertise in Brazil in health insurance and the use of health information technology to improve the support of patients in the community. The Brazilian health insurance market is one of the most dynamic in the adoption of new technologies to improve therapeutic outcomes. Brazil’s population is spread over one of the world’s largest land masses and supporting patients who are far away from hospital is a key priority in improving outcomes of community health.

In addition to the private workshop at HealthBeacon, the delegates participated in the Enterprise Ireland event “Med in Ireland” which is Ireland’s largest medical technologies event and a high-profile showcase for the entire spectrum of the Irish medical technologies sector.

21 Mar

HealthBeacon Grand Opening USA

HealthBeacon Ribbon CuttingBoston, Mass., March, 17, 2017–Medical technology is growing in Boston and for good reason:

Connected medicine is revolutionizing medication adherence. Jim Joyce, creator of the HealthBeacon, believes that connecting real life data about a patient’s behaviour can provide powerful clinical insights and targeted interventions to improve treatment and outcomes. Enter a smart tool for managing medication, the flagship product: The HeathBeacon.

HealthBeacon officially opened their third office at 423 W. Broadway in South Boston, MA on Thursday, March 16th, 2017.  The ceremonial ribbon cutting was performed by Irish Minister Katherine Zappone TD, Minister for Children and Youth Affairs, and accompanied by Fionnuala Quinlan, Consulate General and her team.  This expansion will allow for a North American hub that delivers Irish technology, manufactured in Dublin and exporting it to the world. What better way to drive medical technology growth and development between countries than to have an Irish-American serial entrepreneur leading the way?

Born and raised in Boston, MA, Joyce saw the opportunity that Dublin provides innovative start-up companies. After working several years for a multinational, Joyce decided to venture out on his own and made his first foray into entrepreneurship. His first company, Point of Care, was established in Dublin with the goal of transforming the way patients experience medical treatments in their community. Joyce explains that it was this venture that gave him the idea for the HealthBeacon. He explains “I was originally trying to figure out a way to manage waste disposal and costs, and fumbled my way to an idea that can fundamentally change the pharmaceutical industry.”

HealthBeacon’s digital platform exploits the increased trend in healthcare to connect devices and data for better health delivery. Co- Founder of HealthBeacon, Kieran Daly explains “At HealthBeacon we believe that technology should be near invisible and sophistication should be masked by simplicity. When we thought about how to develop our medical adherence tools we wanted to make sure that the patient experience was frictionless but the impact was meaningful.” It is this seamless connectivity that is driving the internet of things (IoT) trend, and will drive fast adoption and scaling of the platform, especially as it supports lower cost health delivery.

The New England Healthcare Institute estimates that 290 billion dollars is spent each year because of poor medication adherence. Evidence also suggests that patients on average comply with their medication only 52% of the time without digital intervention. Recent studies show that those patients using digital intervention are compliant 77% of the time. We believe that it is this evidence that has led to HealthBeacon’s being embraced by both clinicians and patients.

According to Jim Joyce, “This is the perfect location for an Irish company to launch into the US market. Our Boston team will provide critical technical development and support to pharmaceutical and biotech companies looking to digitally connect their medicines.”

Tim Connelly, Executive Director of the Massachusetts Technology Collaborative, a public economic development agency which promotes the digital health sector across Massachusetts, highlighted the importance of HealthBeacon’s addition to Boston.

“Massachusetts is home to more than 350 digital health organizations working at the intersection of health care and technology,” stated Connelly. “HealthBeacon will find a welcome community of innovators and entrepreneurs, both in healthcare and technology, who can help the company develop, market, and grow their innovative products. As a leading state in healthcare policy, we welcome with open arms companies like HealthBeacon that are working to enhance the delivery of care and ultimately to better the lives of patients.”

09 Jan

HealthBeacon presents at Biotech Showcase

HealthBeacon to present at 9th annual Biotech Showcase in San Francisco

HealthBeacon to present at 9th annual Biotech Showcase in San FranciscoIoT company, HealthBeacon, a leading medical adherence provider will present at the 9th annual Biotech Showcase in San Francisco.

Dublin, Ireland (January 9th, 2017)

A leader in the development of medical adherence solutions for injectable medications, today announced that it is scheduled to present at the 9th Annual Biotech Showcase, being held on January 9-11, 2017 at the Hilton San Francisco Union Square in San Francisco.

Jim Joyce, Chief Executive Officer, will provide an update of the Company’s business during the live presentation and will be available for face-to-face conversations with conference attendees. Details for the presentation are as follows: Date: Wednesday, January 11, 2017 Time: 8:00AM PST.

­­­­­­­About HealthBeacon

HealthBeacon is an Irish-based IoT company developing a digital health platform connecting devices and data for better health delivery. Visit Website >

HealthBeacon, founded in 2014 by both Jim Joyce, serial healthcare entrepreneur, and Kieran Daly, former CEO of Shimmer, developed its first device – to help patients on self injectable medication adhere to their medical schedules.

Medical adherence, helping patients comply with treatment regimens is one of the largest problems facing healthcare systems. Evidence suggests that patients on average comply with their medicine schedules only 50-70% of the time. The pharmaceutical market for patients who self administer medicines by injections is estimated to be over €40b.

Millions of patients worldwide treat devastating chronic diseases like diabetes, multiple sclerosis, arthritis, gastro conditions, and heart disease by self administering injections in their home. Unfortunately, many of these patients struggle to comply with their treatment.

The HealthBeacon team has designed a device that knows when a patient has taken their medication and critically if they have forgotten, or missed a dose. If they miss an injection, their HealthBeacon will send a simple reminder to their phone. The result is potentially a more compliant and healthier patient.

“HealthBeacon is a significant advancement in the management of self injectable medications, we can now have confidence that a patient has taken their medication on time when in the home”, said Professor Douglas Veale, Consultant Rheumatologist, Adjunct Professor of Medicine, University College Dublin.

HealthBeacon’s digital platform exploits the increased trend in healthcare to connect devices and data for better health delivery. The internet of things (IoT) trend will drive fast adoption and scaling of the platform, especially as it supports lower cost health delivery in the community of patients who previously were only administered their treatment in hospital.

For further information please contact:
 Brie Kelly